Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Boston Scientific earned approval from the Food and Drug Administration for its Emblem MRI Subcutaneous Implantable Defibrillator.
The Food and Drug Administration awarded priority review status for a drug intended to treat a childhood-onset form of muscular dystrophy, according to the Chicago Tribune.
The Food and Drug Administration is working to make naloxone more available, stated Karen Mahoney, MD, deputy director for the division of nonprescription drug products at the Center for Drug Evaluation and Research, in a post on the agency's website.
The online market for the sale of illegal drugs has dramatically increased in the last three years, according to a recent study by RAND Europe.
The Texas Medical Center Innovation Institute in Houston welcomed 11 medical device startups to its accelerator program TMCx this week.
AstraZeneca invested an additional $140 million in Moderna Therapeutics, a Cambridge, Mass.-based biotech developing drug treatments using messenger RNA, reported Reuters.
Pressure to slash drug prices from both the Democratic and Republican presidential candidates, as well as leaders and consumer advocates around the globe, could spur changes to the drug pricing model, according to Fortune.
Many Olympic athletes take advantage of a loophole to the anti-doping rules that ban the use of performance enhancing drugs through a practice known as "legal doping," or taking legal prescription medications that may improve performance, according to NPR.
On Saturday, a white male between the ages of 25-40 stole 19 prescriptions from Kilgore's Pharmacy in Columbia, Mo., according to ABC 17 News.
Abbott today introduced Alinity, a unified platform that links immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening, and molecular diagnostics across a health system.